Navigation Links
International Trachoma Initiative and the Task Force for Child Survival and Development Announce New Merger to Eliminate Blinding Trachoma and Fight Against Other Neglected Tropical Diseases
Date:3/18/2009

NEW YORK, March 18 /PRNewswire-USNewswire/ -- The International Trachoma Initiative (ITI) and the Task Force for Child Survival and Development announced today that they will join forces to leverage resources and scale up efforts to eliminate blinding trachoma. Trachoma, a Neglected Tropical Disease (NTD) that is the world's leading cause of preventable blindness, affects 41 million people in 56 countries. While trachoma can be prevented and cured, an estimated 6.8 million people have already lost some or all of their sight to trachoma, and an additional 8.2 million people are at risk of irreversible blindness.

"ITI is excited by the enormous potential that this merger brings to eliminating blinding trachoma," said Ibrahim Jabr, ITI President. "We realized in 2006 that to increase the impact of global trachoma control efforts, ITI would need a complementary partner to help us meet the WHO goal of elimination by 2020. We are confident that the Task Force is that partner."

ITI was created in 1998 through a public-private partnership of the Edna McConnell Clark Foundation and Pfizer, and since then, has been the only global organization dedicated exclusively to the elimination of blinding trachoma.

"Pfizer is confident that the merger between ITI and the Task Force is a positive step forward in ridding the world of blinding trachoma. Pfizer is pleased with the progress we have made with our partners over the last ten years -- providing over a billion dollars of pharmaceutical and financial donations -- that has helped break the cycle of poverty trachoma imposes on millions of families and communities world-wide. We look forward to continuing our support and working through ITI and its Trachoma Expert Committee to provide the Zithromax that will be needed to eliminate blinding trachoma by 2020 and restore the health and well-being of families now and generations to come," said Jeffrey B. Kindler, Chairman and Chief Executive Officer of Pfizer Inc.

"The mission and goals of ITI are a strong complement to the Task Force mission," stated Mark Rosenberg, M.D., Executive Director of the Task Force. "We are at an important juncture for trachoma control efforts and this commitment from Pfizer to supply Zithromax will help mobilize the partners essential to the success of this mission."

ITI is a major proponent and facilitator of the SAFE strategy to prevent, treat and ultimately eliminate blinding trachoma through Surgery, Antibiotics, Facial cleanliness, and Environmental improvements. The Atlanta-based Task Force, working with CARE USA, provides a forum for sharing knowledge and expertise in these four program areas, especially in the area of integration of mass drug administration, sanitation and safe water, and houses programs that address onchocerciasis (river blindness), lymphatic filariasis (elephantiasis), and intestinal worms -- three NTDs whose prevention and treatment could be linked to trachoma control.


'/>"/>
SOURCE The International Trachoma Initiative (ITI)
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. International study strengthens case for daily calcium pill
2. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
3. Australian-led international study shows blood pressure drugs cut death rate in type 2 diabetes
4. LCA Hails International Investigators Studying Lung Cancer
5. Arrow International Urges Shareholders To Vote for Approval of the $45.50 Teleflex Inc. Merger and for the Current Board of Directors
6. PRA International Adds Dr. Susan Stansfield as Executive Vice President
7. Medical Services International Maintains Pace in Second Quarter
8. Clarity Imaging International, Inc. Rolls Out Mobile DEXA Program
9. International Gateway Insurance Brokers Partners With MEDILINQ
10. Tulane University to receive $14M for international HIV/AIDS program
11. International Database Seeks to Boost Treatment of Altitude Sickness
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... ... ... Center for Autism and Related Disorders (CARD) Portland today announced plans to ... and other developmental disabilities. The group, which is being launched with the help of ... to share stories and advice, seek help, and continue their education on how to ...
(Date:12/2/2016)... ... December 02, 2016 , ... Dr. ... will be included in the 2016 “Guide to America’s Top Plastic Surgeons” for ... the amalgamation of their education, experience, and professional associations. , One the ...
(Date:12/2/2016)... ... December 02, 2016 , ... ... diagnostic imaging systems and the first company to offer robotic imaging to ... at their tradeshow booth # 941 for the American Association of Equine Practitioners ...
(Date:12/2/2016)... ... December 02, 2016 , ... Clarify Health ... has raised $6.0 million in an initial round of funding. The round was ... and their caregivers can receive far better care through the application of the ...
(Date:11/30/2016)... , ... November 30, 2016 , ... ... announce that we have been designated as a Cigna Infertility Center of Excellence. ... rigorous performance standards. , “It’s an honor to be designated a Cigna ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... Research and Markets has announced the addition of ... Markets and Companies" to their offering. ... , , ... The market value of drug delivery technologies and the anticancer drugs ... according to organs involved and the types of cancer as well ...
(Date:12/2/2016)... Conn. , Dec. 1, 2016  Today, Simpson ... announced the honor of being selected as winners of ... Simpson Healthcare Executives Website at the PLATINUM level, Blue ... Training Module at the GOLD Level, and our proprietary ... At Simpson Healthcare Executives, we are excited to ...
(Date:12/2/2016)... Dec. 2, 2016  UCB is pleased to announce that 12 ... upcoming 70 th American Epilepsy Society (AES) Annual Meeting, ... TX , USA. 1-12 Data ... profile of VIMPAT ® (lacosamide) CV and BRIVIACT ® ... on the current state of the union of epilepsy care ...
Breaking Medicine Technology: